Business · 30/05/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Pediatric Oncology Subcommittee for Public Comment on Regulatory Issues
Summary
The FDA is hosting a public meeting of the Pediatric Oncology Subcommittee to gather feedback on its regulatory issues, with a public docket established for comments on the meeting and its agenda.